Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,719 | 17 | 51.5% |
| Food and Beverage | $19,650 | 860 | 30.0% |
| Consulting Fee | $7,596 | 4 | 11.6% |
| Travel and Lodging | $4,267 | 17 | 6.5% |
| Education | $301.03 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $37,617 | 69 | $0 (2024) |
| GENZYME CORPORATION | $5,906 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,682 | 145 | $0 (2024) |
| Shire North American Group Inc | $3,803 | 22 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $3,395 | 84 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,693 | 75 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,142 | 51 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $765.97 | 45 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $710.64 | 49 | $0 (2020) |
| CSL Behring | $650.34 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,803 | 83 | AstraZeneca Pharmaceuticals LP ($698.17) |
| 2023 | $3,842 | 121 | Regeneron Healthcare Solutions, Inc. ($1,395) |
| 2022 | $4,182 | 143 | Regeneron Healthcare Solutions, Inc. ($1,295) |
| 2021 | $8,272 | 153 | GENZYME CORPORATION ($4,214) |
| 2020 | $2,055 | 85 | AstraZeneca Pharmaceuticals LP ($602.18) |
| 2019 | $15,747 | 122 | Genentech USA, Inc. ($9,994) |
| 2018 | $17,550 | 117 | Genentech USA, Inc. ($15,259) |
| 2017 | $12,083 | 85 | Genentech USA, Inc. ($10,690) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $15.93 | General |
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $28.53 | General |
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $9.26 | General |
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 524 | 5,934 | $146,825 | $61,546 |
| 2022 | 12 | 502 | 5,350 | $149,938 | $67,241 |
| 2021 | 13 | 673 | 7,094 | $186,930 | $84,874 |
| 2020 | 13 | 594 | 5,449 | $150,865 | $63,003 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 211 | $36,925 | $19,850 | 53.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 53 | 1,230 | $24,600 | $14,401 | 58.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 47 | 2,919 | $32,904 | $8,936 | 27.2% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 40 | 730 | $10,220 | $4,786 | 46.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 25 | 526 | $15,780 | $4,540 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $9,075 | $3,841 | 42.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 95 | 173 | $11,245 | $3,544 | 31.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 32 | 32 | $3,520 | $982.08 | 27.9% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 30 | 30 | $1,350 | $424.80 | 31.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 33 | 33 | $1,155 | $239.04 | 20.7% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2023 | 17 | 17 | $51.00 | $1.70 | 3.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 242 | $42,350 | $23,007 | 54.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 51 | 1,435 | $28,700 | $17,913 | 62.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 37 | 2,205 | $26,460 | $7,222 | 27.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 24 | 512 | $15,360 | $4,579 | 29.8% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 33 | 619 | $8,666 | $4,445 | 51.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 96 | 193 | $12,545 | $3,987 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,775 | $2,277 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,225 | $2,094 | 49.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 30 | 31 | $3,410 | $1,016 | 29.8% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 27 | 29 | $1,305 | $404.57 | 31.0% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 30 | 31 | $1,085 | $294.66 | 27.2% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2022 | 19 | 19 | $57.00 | $1.90 | 3.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 284 | $49,700 | $27,908 | 56.2% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 50 | 1,250 | $25,000 | $16,267 | 65.1% |
About Dr. William Lanting, M.D
Dr. William Lanting, M.D is a Allergy healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205866837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lanting, M.D has received a total of $65,533 in payments from pharmaceutical and medical device companies, with $1,803 received in 2024. These payments were reported across 909 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,719).
As a Medicare-enrolled provider, Lanting has provided services to 2,293 Medicare beneficiaries, totaling 23,827 services with total Medicare billing of $276,664. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Location Fort Collins, CO
- Active Since 07/03/2006
- Last Updated 08/05/2015
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1205866837
Products in Payments
- Xolair (Biological) $37,589
- DUPIXENT (Biological) $8,536
- NUCALA (Biological) $1,228
- TEZSPIRE (Biological) $1,159
- NURTEC ODT (Drug) $990.79
- FASENRA (Biological) $990.65
- HYQVIA (Biological) $912.70
- FASENRA (Drug) $861.16
- SYMBICORT (Drug) $747.89
- DUPIXENT (Drug) $533.12
- CUTAQUIG (Biological) $408.76
- Hizentra (Biological) $385.72
- AirDuo Digihaler (Drug) $367.04
- XOLAIR (Biological) $330.38
- LONHALA MAGNAIR (Drug) $287.40
- TAKHZYRO (Biological) $286.22
- UBRELVY (Drug) $278.10
- CUVITRU (Biological) $277.73
- UTIBRON (Drug) $268.83
- TRELEGY ELLIPTA (Drug) $261.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.